Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
+705.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
521.9x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 740.57 | +555.0% |
| 2024 | 113.06 | +508.9% |
| 2023 | -27.65 | -2048.8% |
| 2022 | 1.42 | -98.1% |
| 2021 | 75.73 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |